Advertisement

Story About the Development of an Insomnia Drug Won't Put You to Sleep — Physician’s First Watch

Medical News |
December 9, 2013

Story About the Development of an Insomnia Drug Won't Put You to Sleep

By the Editors

Your patients may ask about an article in the current New Yorker that details the development of suvorexant, a drug for insomnia that targets orexin, the brain's "Stay awake!" switch.

While telling the suvorexant story, the piece offers a brief history of earlier attempts to treat sleeplessness safely — the benzodiazepines (notably Halcion) and zolpidem (Ambien) — with the latter drug earning the sobriquet "the devil's aspirin" from Charlie Sheen.

It's interesting stuff that we guarantee won't induce drowsiness.

Reader Comments (2)

Melvin Breite MD Physician, Internal Medicine, office Queens NY

How can you forget methaqualone (aka Quaalude and Parest) that were freely sampled in the 70's)?

giuseppe

welcome

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement